RECRUITING

Strategy Training for Individuals With Unilateral Neglect

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

It is common for individuals after stroke to have a cognitive perceptual impairment called unilateral spatial neglect (neglect). Individuals with neglect have difficulty paying attention to one side of their body or one side of the environment and therefore experience difficulty performing daily activities. There are a lack of effective treatments for neglect and new interventions are needed to help reduce disability for these individuals. Metacognitive strategy training (strategy training) is an intervention that has the potential to reduce neglect-related disability and improve individuals' awareness of their neglect. This study seeks to examine the effects of strategy training on self-awareness, disability, and neglect.

Official Title

Examining Metacognitive Strategy Training for Individuals With Unilateral Spatial Neglect

Quick Facts

Study Start:2024-08-16
Study Completion:2025-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06400147

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * primary diagnosis of stroke
  2. * admission to inpatient rehabilitation facility
  3. * ≥18 years old
  4. * presence of neglect as determined by score of \<18 on the Virtual Reality Lateralized Attention Test (VRLAT) or score below established cutoff for neglect on one of the six subtests of the Behavioral Inattention Test (BIT)
  1. * Boston Diagnostic Aphasia Examination (BDAE) Severity Scale score of 0 (severe global aphasia)
  2. * diagnosis of dementia indicated in medical record
  3. * diagnosis of active major depressive disorder/bipolar/psychotic disorder indicated in medical record
  4. * anticipated length of stay \<10 days

Contacts and Locations

Study Contact

Emily Grattan, PhD
CONTACT
412-648-0619
esg39@pitt.edu

Principal Investigator

Emily Grattan, PhD
PRINCIPAL_INVESTIGATOR
University of Pittsburgh

Study Locations (Sites)

University of Pittsburgh
Pittsburgh, Pennsylvania, 15219
United States

Collaborators and Investigators

Sponsor: University of Pittsburgh

  • Emily Grattan, PhD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-16
Study Completion Date2025-12-01

Study Record Updates

Study Start Date2024-08-16
Study Completion Date2025-12-01

Terms related to this study

Additional Relevant MeSH Terms

  • Stroke
  • Neglect, Hemispatial